Next, we assessed whether IL2RB expression is associated with increased immune-checkpoint expression using single CD8+ T-cell RNA-seq data (n = 1192) from MC38 colon cancer mouse models, treated with immune checkpoint therapy GSE120909. This evidence concerns the gene CD8A and malignant colon neoplasm.